Ithax Pharmaceuticals Inc.
Seattle, WA
- UEI
- D6ZLMK2SMHJ5
- CAGE
- 82KF3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2815 Eastlake Ave E #300, Seattle, WA 98102, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Small molecule inhibitors of oncogenic MIR-21 | National Cancer Institute (NIH) | $249,109 | |
| New inhibitors of HIV latency reactivation | National Institute of Allergy and Infectious Diseases (NIH) | $1,183,323 |
Quick answers
Is Ithax Pharmaceuticals Inc. registered in SAM.gov?
Yes. Ithax Pharmaceuticals Inc.'s SAM.gov registration is active through September 17, 2027.
What is Ithax Pharmaceuticals Inc.'s most recent federal award?
Ithax Pharmaceuticals Inc.'s most recent federal grant award is Small molecule inhibitors of oncogenic MIR-21 (R41CA254746), from National Cancer Institute (NIH), on August 14, 2020.
On GovTribe
See Ithax Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors